New Hampshire rabies titer exemption bill stalls after pushback

New Hampshire’s HB 1488 put a familiar client concern into statutory form: could a pet with documented rabies antibodies avoid another booster shot? The bill proposed a new exemption pathway for dogs, cats, and ferrets, allowing a single licensed veterinarian to support an exemption if the animal met a titer-testing protocol, rather than limiting exemptions to more traditional medical contraindications. The idea drew immediate pushback from public health and veterinary voices, and it has not advanced into law. Citizens Count, which tracks official state data, lists the bill as sent to interim study and not enacted as of March 31, 2026. (citizenscount.org)

The backdrop is New Hampshire’s existing rabies framework, which already requires an initial vaccination and follow-up boosters on a schedule tied to the National Association of State Public Health Veterinarians’ Compendium of Animal Rabies Prevention and Control. HB 1488 would have rewritten that section of law to preserve the standard initial series while adding a second type of exemption. One route would still rely on written recommendations involving a veterinarian, an ACVIM diplomate, and the state veterinarian for animals with illness or medical conditions that preclude vaccination. The new route would have allowed a single veterinarian to issue an exemption based on titer testing. (legiscan.com)

The bill text laid out a specific testing sequence. A veterinarian would perform a baseline rabies antibody titer before vaccination, then a second titer 7 to 14 days after vaccination to establish that animal’s individual immune response. Future exemption testing would need to show antibody levels equal to or higher than that post-vaccination baseline. Animals exempted for medical reasons would still face strict isolation, leash, and muzzle requirements, but animals exempted through titer-based “demonstrated immunity” would not. That distinction is one reason the proposal drew scrutiny: it would have treated titer-positive animals as functionally exempt from both revaccination and some control measures. (legiscan.com)

Outside reporting added two practical details that matter in clinic conversations. First, the proposal was reportedly introduced at a constituent’s request tied to concerns about vaccine side effects. Second, obtaining the testing would not be trivial or cheap. Vet Candy’s coverage said only two U.S. laboratories perform these rabies antibody tests for this purpose and estimated costs at roughly $300 to $500. Rabies Aware, a widely used educational resource, similarly notes that rabies virus neutralizing antibody testing is generally limited to authorized laboratories and is most commonly used for pet travel, not routine substitution for domestic rabies revaccination. (newhampshirebulletin.com)

The scientific and regulatory objection has been consistent. New Hampshire State Veterinarian Mark Prescott said the bill was not grounded in solid data and that current research does not establish a reliable antibody threshold proving immunity in domestic animals. AAHA’s canine vaccination guidance states that antibody titer levels as correlates of protection have not been established for rabies and that serologic testing is not considered a substitute for vaccination. Rabies Aware goes even more plainly, noting that a “positive” rabies virus neutralizing antibody result means an animal mounted an immune response after vaccination, but it is not interpreted as proof of immunity or protection if the animal is exposed. (newhampshirebulletin.com)

Why it matters: For veterinarians, this isn’t just a vaccine scheduling debate. Rabies occupies a different category from most companion animal immunizations because it sits at the intersection of patient care, public health law, bite management, municipal enforcement, and human exposure risk. If more states entertain titer-based exemptions, practitioners could face growing pressure from pet parents who view rabies titers the same way they view distemper or parvo titers, even though the legal and scientific frameworks are different. That raises documentation burdens, informed-consent challenges, and potential confusion during exposure investigations, especially if a pet has measurable antibodies but is still considered unvaccinated under prevailing guidance. (aaha.org)

There’s also a policy signal here. New Hampshire Bulletin reported HB 1488 amid a broader 2026 push from vaccine-skeptical lawmakers on multiple immunization-related bills. In that context, rabies policy may become a testing ground for broader arguments about medical autonomy, individualized risk, and distrust of standard schedules. For veterinary teams, that means client education will matter as much as statutory tracking: practices may need to explain not only what the law requires, but why rabies rules remain more rigid than other vaccine decisions. (newhampshirebulletin.com)

What to watch: The immediate bill is stalled, but interim study often keeps an idea alive rather than killing it outright. Watch for a refiled measure in the next New Hampshire session, possible narrowing toward medical exemptions only, or efforts in other states to import similar titer-based language. Also watch whether veterinary associations or public health groups issue more explicit state-level talking points, since this issue is likely to come back wherever vaccine hesitancy and adverse-event concerns intersect with rabies law. (citizenscount.org)